BackJanux Therapeutics Overview

Janux Therapeutics Net Income

Profitability analysis for JANX.

Quarterly Net Income

-$24.36M
3.63% YoY

As of Mar 2026

Annual Net Income (TTM)

-$158.52M
103.91% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...